phosphatidylcholines has been researched along with alendronate in 2 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (alendronate) | Trials (alendronate) | Recent Studies (post-2010) (alendronate) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 4,096 | 731 | 1,724 |
Protein | Taxonomy | phosphatidylcholines (IC50) | alendronate (IC50) |
---|---|---|---|
Chain A, farnesyl pyrophosphate synthase | Trypanosoma cruzi | 147 | |
Farnesyl pyrophosphate synthase | Homo sapiens (human) | 0.7523 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blank, MA; Gibson, GW; Lichtenberger, LM; Romero, JJ | 1 |
Ha, DH; Han, HK; Shin, HJ | 1 |
2 other study(ies) available for phosphatidylcholines and alendronate
Article | Year |
---|---|
Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Diphosphonates; Etidronic Acid; Gastric Mucosa; Indomethacin; Male; Pamidronate; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Risedronic Acid; Surface Properties | 2000 |
Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
Topics: Adhesiveness; Administration, Oral; Alendronate; Animals; Biological Availability; Bone Density Conservation Agents; Caco-2 Cells; Chemistry, Pharmaceutical; Chitosan; Drug Stability; Humans; Intestinal Absorption; Intestinal Mucosa; Lipids; Liposomes; Male; Mucins; Nanoparticles; Particle Size; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Technology, Pharmaceutical | 2012 |